Compare ESP & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESP | VYGR |
|---|---|---|
| Founded | 1928 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.4M | 194.0M |
| IPO Year | 1995 | 2015 |
| Metric | ESP | VYGR |
|---|---|---|
| Price | $56.40 | $3.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $64.00 | $21.00 |
| AVG Volume (30 Days) | 12.3K | ★ 879.5K |
| Earning Date | 05-11-2026 | 03-09-2026 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | ★ 31.88 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $43,950,872.00 | $10,135,000.00 |
| Revenue This Year | $10.30 | $33.19 |
| Revenue Next Year | $10.00 | $14.68 |
| P/E Ratio | $31.87 | ★ N/A |
| Revenue Growth | ★ 13.46 | N/A |
| 52 Week Low | $24.85 | $2.65 |
| 52 Week High | $62.15 | $5.55 |
| Indicator | ESP | VYGR |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 48.26 |
| Support Level | $52.83 | $3.61 |
| Resistance Level | $61.58 | $4.43 |
| Average True Range (ATR) | 2.52 | 0.31 |
| MACD | -0.15 | -0.04 |
| Stochastic Oscillator | 53.69 | 20.16 |
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.